Literature DB >> 25451367

Acute coronary syndrome after nasal spray of oxymetazoline.

François Montastruc1, Guillaume Montastruc2, Marie-Josée Taudou3, Pascale Olivier-Abbal1, Jean-Louis Montastruc1, Emmanuelle Bondon-Guitton4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25451367     DOI： 10.1378/chest.14-1873

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

1.  Effect of Intranasal Vasoconstrictors on Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Shawna D Bellew; Katie L Johnson; Micah D Nichols; Tobias Kummer
Journal:  J Emerg Med       Date:  2018-09-06       Impact factor: 1.484

2.  Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey.

Authors:  Margaux Lafaurie; Pascale Olivier; Charles Khouri; Marina Atzenhoffer; Kévin Bihan; Geneviève Durrieu; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2019-12-20       Impact factor: 2.953

3.  Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study.

Authors:  Lamiae Grimaldi-Bensouda; Bernard Begaud; Jacques Benichou; Clementine Nordon; Olivia Dialla; Nicolas Morisot; Yann Hamon; Yves Cottin; Elie Serrano; Lucien Abenhaim; Emmanuel Touzé
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.